Lymph nodes can be the primary target of infection or malignant transformat
ion and may exhibit characteristic patterns of leukocyte infiltration analo
gous to those seen in inflammation of other tissues. Leukocyte migration to
lymph nodes in vivo is a highly regulated, multi-step process that depends
upon adhesion molecules and as yet, uncharacterized chemotactic signals. C
hemokines are a key part of the orchestrated code of signals that directs l
eukocyte subsets to sites of inflammation or immune response. The potential
role of these chemoattractants in selective trafficking of leukocyte subse
ts into lymph nodes was assessed by determining the expression of chemokine
s on a range of pathological and normal human lymph nodes and by evaluating
the cellular composition of each lymph node. In situ hybridization using c
hemokine riboprobes and immunohistochemistry using specific antibodies were
performed in order to correlate the mRNA and protein expression of the che
mokines, The cellular source(s) of each chemokine was assessed by immunohis
tochemical staining of adjacent sections using antibodies directed against
distinctive cellular markers, Substantial, but varied, expression of macrop
hage inflammatory protein (MIP)-1 alpha, MIP-1 beta, RANTES, macrophage che
motactic protein (MCP)-1, eotaxin, and interleukin 8 (IL-8) were detected i
n the pathological lymph nodes by diverse cell types. Control lymph nodes s
howed expression only of RANTES, mainly by high endothelial venules, In all
lymph nodes, except the nodes infiltrated with breast cancer, chemokine mR
NA expression was highly concordant with the corresponding protein. In cont
rast with in vitro studies that have suggested discrete target cell specifi
city of chemokines, this study showed that with the possible exception of t
he neutrophil chemoattractant, IL-8, no chemokine appeared to be uniquely a
ssociated with the accumulation of a specific leukocyte subset. These data
implicate chemokines in the recruitment of leukocytes to lymph nodes affect
ed by diverse disease states. (C) 1999 Academic Press.